Date: 12th – 13th April 2024
Attention!
The social meeting will take place on the 12th of April 2024 at 20.00 at the Sarp club-gallery.
| Friday 12th April 2024 | |
|---|---|
| Session: Skin Cancers | |
| 1000–1005 | Opening |
| 1005–1030 | LECTURE: The evolving paths in NMSC Prof. Iris Zalaudek, MD, PhD |
| 1030–1050 | LECTURE: Dermoscopy in melanoma and Merkel cell carcinoma Prof. Grażyna Kamińska-Winciorek, MD, PhD |
| 1050–1110 | LECTURE: Salvage irradiation for skin cancer recurrence Dr Luca Tagliaferri, MD, PhD |
| 1110–1130 | LECTURE: Salvage treatment for melanoma recurrence Prof. Mateusz Spałek, MD, PhD |
| 1130–1150 | LECTURE: Surgical treatment in skin cancer recurrence Prof. Wojciech Wysocki, MD, PhD |
| 1150–1205 | Break |
| 1205–1245 | DISCUSSION: The role of the multidisciplinary team in case of skin cancer radical treatment failure Dr Luca Tagliaferri, MD, PhD Prof. Vratislav Strnad, MD, PhD Prof. Grażyna Kamińska-Winciorek, MD, PhD Prof. Mateusz Spałek, MD, PhD Dr Artur Chyrek, MD, PhD Prof. Piotr Wojcieszek, MD, PhD |
| Session: Miscellaneous | |
| 1300–1315 | LECTURE: Brachytherapy in the treatment of liver lesions Dr Mateusz Bilski, MD, PhD |
| 1315–1335 | LECTURE: Radiobiology of cancer recurrence Prof. Georges Noel, MD, PhD |
| 1335–1420 | Break |
| Session: Gynaecologic Cancers | |
| 1420–1440 | LECTURE: Treatment of cervical cancer failure – the role of radiotherapy Prof. Supriya Chopra, MD, PhD |
| 1440–1500 | LECTURE: Treatment of gynaecologic cancer failure – the role of systemic treatment Dr Katarzyna Drosik-Rutowicz, MD |
| 1500–1520 | LECTURE: Treatment of endometrial cancer failure – the role of radiotherapy Dr Alina Sturdza, MD, PhD |
| 1520–1540 | SPONSORED LECTURE – GSK: Treatment of endometrial cancer failure – the role of immunotherapy Prof. Rafał Tarnawski, MD, PhD |
| 1540–1640 | DISCUSSION: The role of the multidisciplinary team in case of gynaecologic cancer radical treatment failure Prof. Małgorzata Klimek, MD, PhD Prof. Vratislav Strnad, MD, PhD Dr Alina Sturdza, MD, PhD Prof. Supriya Chopra, MD, PhD Prof. Rafał Tarnawski, MD, PhD Dr Magdalena Stankiewicz, MD, PhD |
| 1640–1645 | Closing remarks |
| Saturday 13th April 2024 | |
|---|---|
| Session: Prostate Cancer | |
| 0900–0910 | Opening |
| 0910–0930 | LECTURE: MRI imaging in prostate cancer recurrence Dr Justyna Rembak-Szynkiewicz, MD, PhD |
| 0930–0950 | LECTURE: Histopathology of prostate cancer recurrence Dr Piotr Paul, MD |
| 0950–1010 | LECTURE: PET PSMA imaging in prostate cancer recurrence Dr Andrea d’Amico, MD, PhD |
| 1010–1045 | DISCUSSION: When to start diagnostic imaging? Prof. Vratislav Strnad, MD, PhD Dr Hathal Haddad, MD Dr Justyna Rembak-Szynkiewicz, MD, PhD Dr Magdalena Stankiewicz, MD, PhD Prof. Piotr Wojcieszek, MD, PhD |
| 1045–1100 | Break |
| 1100–1120 | WYKŁAD SPONSOROWANY – ASTELLAS: Możliwości terapeutyczne u pacjentów z przerzutowym opornym na kastrację rakiem gruczołu krokowego (mCRPC) – dane z rzeczywistej praktyki klinicznej Dr Dawid Sigorski, MD, PhD |
| 1120–1150 | DISCUSSION: When to perform a biopsy? Dr Justyna Rembak-Szynkiewicz, MD, PhD Prof. Piotr Bryniarski, MD, PhD Prof. Wojciech Majewski, MD, PhD Dr Artur Chyrek, MD, PhD Prof. Piotr Wojcieszek, MD, PhD |
| 1150–1220 | DISCUSSION: … or maybe salvage prostatectomy? Prof. Piotr Bryniarski, MD, PhD Prof. Bartosz Małkiewicz, MD, PhD Dr Francesco Alessandro Mistretta, MD, PhD Prof. Wojciech Majewski, MD, PhD Prof. Piotr Wojcieszek, MD, PhD |
| 1220–1240 | LECTURE: Salvage treatment options in prostate cancer recurrence – the urologist’s view Dr Francesco Alessandro Mistretta, MD, PhD |
| 1240–1300 | LECTURE: Salvage treatment options in prostate cancer recurrence – the radiation oncologist’s view Prof. Vratislav Strnad, MD, PhD |
| 1300–1315 | WYKŁAD SPONSOROWANY – RECORDATI: “Survival is not enough” – leczenie hormonalne w kontekście jakości życia pacjenta Dr Magdalena Stankiewicz, MD, PhD |
| 1315–1400 | Break |
| 1400–1420 | LECTURE: Metastasis-directed therapy for oligometastatic prostate cancer Prof. Wojciech Majewski, MD, PhD |
| 1420–1500 | DISCUSSION: Is ADT indicated (patient selection, duration)? Prof. Wojciech Majewski, MD, PhD Prof. Bartosz Małkiewicz, MD, PhD Dr Hathal Haddad, MD Dr Magdalena Stankiewicz, MD, PhD Prof. Piotr Wojcieszek, MD, PhD |
| 1500–1520 | WYKŁAD SPONSOROWANY – BAYER: Rola onkologa-radioterapeuty w diagnostyce pacjentów nmCRPC – doświadczenia własne, opis przypadku Dr Magdalena Stankiewicz, MD, PhD |
| 1520–1550 | DISCUSSION: Second-line treatment in M0 and M1 patients? Prof. Wojciech Majewski, MD, PhD Prof. Piotr Bryniarski, MD, PhD Dr Katarzyna Drosik-Rutowicz, MD Dr Magdalena Stankiewicz, MD, PhD |
| 1550–1610 | SPONSORED LECTURE – JANSSEN: TBA Prof. Piotr Wojcieszek, MD, PhD |
| 1610–1615 | Closing Remarks |